Medical research
Abveris
Abveris is a leading antibody discovery company based in Canton, MA, specializing in the development of biologics for therapeutic and reagent antibody targets. With a strong reputation for delivering outstanding science, Abveris offers industry-leading antibody discovery solutions for challenging classes of targets, including cell surface receptors and difficult-to-target molecules such as GPCR and ion channels. Their end-to-end antibody discovery technologies, including repertoire generation, advanced screening, characterization, and recombinant expression, enable them to provide custom-built solutions for biotech and biopharma companies of all sizes. With expertise in antibody discovery and a fee-for-service, royalty-free partnership model, Abveris supports the development efforts of their partners in various fields, including cell therapies, point-of-care diagnostics, and clinical trials. Their proprietary hyperimmune mouse model, DiversimAb approach, and humanized mice enable rapid and high-resolution single B cell screening, epitope binning, and on-cell binding assays. Abveris' commitment to delivering high-quality clones and analytical data, along with their collaborative spirit, has earned them the trust of pharmaceutical and biotech companies in their pursuit of effective antibody discovery.Generated from the website